Trial Profile
Effect nilotinib and its association with onset of cardio-vascular events in patients with Chronic Myelogenous Leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2015
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary) ; Imatinib
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions
- 18 Jun 2015 New trial record